Surgepays Stock Performance
| SURG Stock | USD 1.75 0.05 2.78% |
Surgepays has a performance score of 1 on a scale of 0 to 100. The entity has a beta of 2.06, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Surgepays will likely underperform. Surgepays right now has a risk of 5.92%. Please validate Surgepays potential upside, as well as the relationship between the kurtosis and day typical price , to decide if Surgepays will be following its existing price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Surgepays are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Surgepays is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Last Split Factor 1:50 | Last Split Date 2021-11-02 |
1 | Acquisition by Kevin Cox of 83333 shares of Surgepays subject to Rule 16b-3 | 08/30/2024 |
2 | Disposition of 35100 shares by Kevin Cox of Surgepays at 1.4782 subject to Rule 16b-3 | 09/03/2024 |
3 | Disposition of 100 shares by Schurfeld Richard Earl of Surgepays at 0.03 subject to Rule 16b-3 | 09/09/2024 |
4 | Disposition of 22900 shares by Schurfeld Richard Earl of Surgepays at 0.0092 subject to Rule 16b-3 | 09/11/2024 |
5 | Acquisition by Schurfeld Richard Earl of 1800 shares of Surgepays at 1.5 subject to Rule 16b-3 | 09/13/2024 |
6 | Disposition of tradable shares by Evers Anthony George of Surgepays at 3.0 subject to Rule 16b-3 | 09/16/2024 |
7 | SurgePays director Schurfeld trades company stock | 09/20/2024 |
8 | Discretionary transaction by Schurfeld Richard Earl of tradable shares of Surgepays subject to Rule 16b-3 | 09/23/2024 |
9 | Acquisition by Evers Anthony George of 66667 shares of Surgepays subject to Rule 16b-3 | 10/01/2024 |
10 | Disposition of 36667 shares by Evers Anthony George of Surgepays at 1.5376 subject to Rule 16b-3 | 10/02/2024 |
11 | SurgePays CFO Anthony Evers sells shares worth over 56k | 10/03/2024 |
12 | Synergetics.ai Named to Guidewire Insurtech Vanguards Program | 10/15/2024 |
13 | Disposition of 36667 shares by Evers Anthony George of Surgepays at 1.6 subject to Rule 16b-3 | 11/01/2024 |
14 | Disposition of 31700 shares by Kevin Cox of Surgepays at 1.595 subject to Rule 16b-3 | 11/04/2024 |
15 | Surgepays GAAP EPS of -0.73 misses by 0.46, revenue of 4.77M misses by 3.87M | 11/12/2024 |
16 | SurgePays, Inc. Reports Q3 Loss, Misses Revenue Estimates | 11/13/2024 |
17 | SurgePays Third Quarter 2024 Earnings Misses Expectations | 11/15/2024 |
18 | SurgePays Teams Up With ATT For Affordable Wireless Solutions Nationwide Stock Gains | 11/21/2024 |
19 | Memphis-area company announces multiyear deal with ATT | 11/22/2024 |
| Begin Period Cash Flow | 7 M | |
| Free Cash Flow | 10 M |
Surgepays |
Surgepays Relative Risk vs. Return Landscape
If you would invest 183.00 in Surgepays on August 27, 2024 and sell it today you would lose (8.00) from holding Surgepays or give up 4.37% of portfolio value over 90 days. Surgepays is currently generating 0.0967% in daily expected returns and assumes 5.9244% risk (volatility on return distribution) over the 90 days horizon. In different words, 52% of stocks are less volatile than Surgepays, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Surgepays Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Surgepays' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Surgepays, and traders can use it to determine the average amount a Surgepays' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0163
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | SURG | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.92 actual daily | 52 52% of assets are less volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Surgepays is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Surgepays by adding it to a well-diversified portfolio.
Surgepays Fundamentals Growth
Surgepays Stock prices reflect investors' perceptions of the future prospects and financial health of Surgepays, and Surgepays fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Surgepays Stock performance.
| Return On Equity | -0.0519 | ||||
| Return On Asset | -0.0151 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | (0.72) % | ||||
| Current Valuation | 16.05 M | ||||
| Shares Outstanding | 20.16 M | ||||
| Price To Earning | 11.14 X | ||||
| Price To Book | 1.06 X | ||||
| Price To Sales | 0.31 X | ||||
| Revenue | 137.14 M | ||||
| Gross Profit | 13.47 M | ||||
| EBITDA | 20.08 M | ||||
| Net Income | 20.62 M | ||||
| Cash And Equivalents | 8.7 M | ||||
| Cash Per Share | 0.70 X | ||||
| Total Debt | 5.44 M | ||||
| Debt To Equity | 6.32 % | ||||
| Current Ratio | 1.07 X | ||||
| Book Value Per Share | 1.96 X | ||||
| Cash Flow From Operations | 10.29 M | ||||
| Earnings Per Share | (1.18) X | ||||
| Market Capitalization | 35.28 M | ||||
| Total Asset | 41.93 M | ||||
| Retained Earnings | (15.19 M) | ||||
| Working Capital | 20.66 M | ||||
| Current Asset | 46.28 M | ||||
| Current Liabilities | 9.69 M | ||||
About Surgepays Performance
By analyzing Surgepays' fundamental ratios, stakeholders can gain valuable insights into Surgepays' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Surgepays has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Surgepays has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 32.53 | 34.16 | |
| Return On Tangible Assets | 0.55 | 0.58 | |
| Return On Capital Employed | 0.65 | 0.68 | |
| Return On Assets | 0.49 | 0.52 | |
| Return On Equity | 0.73 | 0.69 |
Things to note about Surgepays performance evaluation
Checking the ongoing alerts about Surgepays for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Surgepays help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Surgepays had very high historical volatility over the last 90 days | |
| Surgepays may become a speculative penny stock | |
| About 32.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from bizjournals.com: Memphis-area company announces multiyear deal with ATT |
- Analyzing Surgepays' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Surgepays' stock is overvalued or undervalued compared to its peers.
- Examining Surgepays' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Surgepays' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Surgepays' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Surgepays' stock. These opinions can provide insight into Surgepays' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |